Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15-Reference-Cited by-同舟云学术

Efficacy, Safety, and Pharmacokinetics of Inclisiran in Japanese Patients: Results from ORION-15

Published:2024-06-01 Issue:6 Volume:31 Page:876-903
ISSN:1340-3478
Container-title:Journal of Atherosclerosis and Thrombosis
language:en
Short-container-title:JAT

Author:

Yamashita Shizuya¹,Kiyosue Arihiro²,Maheux Pierre³,Mena-Madrazo Jorge³,Lesogor Anastasia³,Shao Qing⁴,Tamaki Yuko⁵,Nakamura Hidekazu⁵,Akahori Mizuki⁵,Kajinami Kouji⁶

Affiliation:

1. Department of Cardiology, Rinku General Medical Center

2. Tokyo-Eki Center-building Clinic

3. Novartis Pharma AG

4. Novartis Pharmaceuticals Corporation

5. Novartis Pharma K.K.

6. Kanazawa Medical University

Publisher

Japan Atherosclerosis Society

Link

https://www.jstage.jst.go.jp/article/jat/31/6/31_64454/_pdf

Reference38 articles.

1. 1) WHO. Cardiovascular diseases. Available at: https: //www.who.int/health-topics/cardiovascular-diseases#tab=tab_1. Accessed: July 24, 2023

2. 2) Hirata K, Matsumoto K, Hatakeyama Y, Onishi R, Seto K, Hasegawa T. Social burden of three major diseases in Japan: A time trend and future projections using the comprehensive cost of illness method. PLoS One, 2023; 18: e0280311

3. 3) Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB, Pasternak RC, Smith Jr SC, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. Circulation, 2004; 110: 227-239

4. 4) Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation, 2014; 129: 399-410

5. 5) Fitzgerald K, White S, Borodovsky A, Bettencourt BR, Strahs A, Clausen V, Wijngaard P, Horton JD, Taubel J, Brooks A, Fernando C. A highly durable RNAi therapeutic inhibitor of PCSK9. N Engl J Med, 2017; 376: 41-51

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse events associated with inclisiran: a real-world disproportionality analysis based on the FAERS database;Expert Opinion on Drug Safety;2024-08-12